SCHEMBL5128271

SCHEMBL5128271

O=CC1=NCCc2ccccc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 2/20 0.55
NOS2 P35228 1/20 0.55
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.47
MAOA P21397 2/20 0.45
CES1 P23141 1/20 0.43
MAOB P27338 2/20 0.39
CYP2A6 P11509 1/20 0.39
PARP1 P09874 2/20 0.37
PDPK1 O15530 1/20 0.37
PARP10 Q53GL7 1/20 0.37
PARP11 Q9NR21 1/20 0.37
CYP19A1 P11511 5/20 0.37
CYP11B2 P19099 3/20 0.36
CYP11B1 P15538 1/20 0.36
MIF P14174 1/20 0.36
PKM P14618 1/20 0.36
MAPK1 P28482 1/20 0.36
SLC22A1 O15245 1/20 0.35
CACNA1F O60840 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24224408 0.80 NOS3 (0.55) NOS3NOS2KDM4EALDH1A1MAOA
SCHEMBL8523656 0.76 NOS3 (0.50) NOS3NOS2KDM4EALDH1A1MAOA
SCHEMBL8523658 0.76 NOS3 (0.50) NOS3NOS2KDM4EALDH1A1MAOA
SCHEMBL28785652 0.74 PARP10 (0.44) PARP10PARP11CYP19A1CYP11B2CYP11B1
SCHEMBL28843253 0.74 NOS3 (0.49) NOS3NOS2KDM4EALDH1A1MAOA
SCHEMBL11488708 0.71 NOS3 (0.59) NOS3NOS2KDM4EALDH1A1MAOA
SCHEMBL13783121 0.71 NOS3 (0.64) NOS3NOS2KDM4EALDH1A1MAOA
SCHEMBL11267501 0.71 NOS3 (0.59) NOS3NOS2KDM4EALDH1A1MAOA
SCHEMBL30310 0.71 NOS3 (0.59) NOS3NOS2KDM4EALDH1A1MAOA
SCHEMBL4997776 0.71 NOS3 (0.59) NOS3NOS2KDM4EALDH1A1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115093369-B Synthesis method of 3, 4-dihydro-isoquinoline-1-ketone compound 浙大城市学院 2024-05-10 CN claimed
CN-117304099-A Benzene ring compound and application thereof 上海施江医药科技有限公司 2023-12-29 CN claimed
CN-117209424-A Benzene ring compound and application thereof in anti-tumor aspect 上海施江医药科技有限公司 2023-12-12 CN claimed
CN-115093369-A Synthetic method of 3, 4-dihydroisoquinoline-1-ketone compound 浙大城市学院 2022-09-23 CN claimed
CN-107778238-B Novel synthesis method of 3, 4-dihydroisoquinoline-1-ketone 中山大学 2022-07-22 CN claimed
CN-107778238-A A kind of new synthetic method of the ketone of 3,4 dihydro-isoquinoline 1 and isoindoline 1 ketone derivatives 中山大学 2018-03-09 CN claimed
CN-107531690-A The amines of 4,5,6,7 tetrahydrochysene 1H pyrazolos [4,3 c] pyridine 3 as CBP and/or EP300 inhibitor 基因泰克公司 2018-01-02 CN claimed
CN-115093369-B Synthesis method of 3, 4-dihydro-isoquinoline-1-ketone compound 浙大城市学院 2024-05-10 CN disclosed
CN-115093369-B Synthesis method of 3, 4-dihydro-isoquinoline-1-ketone compound 浙大城市学院 2024-05-10 CN disclosed
CN-115093369-B Synthesis method of 3, 4-dihydro-isoquinoline-1-ketone compound 浙大城市学院 2024-05-10 CN disclosed
CN-117304099-A Benzene ring compound and application thereof 上海施江医药科技有限公司 2023-12-29 CN disclosed
CN-117209424-A Benzene ring compound and application thereof in anti-tumor aspect 上海施江医药科技有限公司 2023-12-12 CN disclosed
CN-117186090-A Benzene ring compound and application thereof 上海施江医药科技有限公司 2023-12-08 CN disclosed
CN-107531690-A The amines of 4,5,6,7 tetrahydrochysene 1H pyrazolos [4,3 c] pyridine 3 as CBP and/or EP300 inhibitor 基因泰克公司 2018-01-02 CN disclosed
CN-106852142-A As the spiral shell diamine derivative of aldosterone synthase inhibitors 豪夫迈·罗氏有限公司 2017-06-13 CN disclosed
CN-105566221-A Synthetic method for condensed ring amide compound GAO YUHUA 2016-05-11 CN disclosed
CN-102448548-A Heterocyclic antiviral compounds HOFFMANN LA ROCHE 2012-05-09 CN disclosed
US-20080167314-A1 Condensed Imidazole Compound And Use Thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-07-10 US disclosed
EP-1832588-A1 CONDENSED IMIDAZOLE COMPOUND AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2007-09-12 EP disclosed
CN-1135212-A polar substituted hydrocarbons NARHEX AUSTRALIA PTY LTD (AU) 1996-11-06 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080167314-A1 Condensed Imidazole Compound And Use Thereof MAPK13, MMP13, MAPK3 NOS3 11/4885NOS2 44/4885KDM4E 1737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.